SpringWorks Therapeutics, Inc.·4

Jul 14, 4:28 PM ET

Smith L. Mary 4

4 · SpringWorks Therapeutics, Inc. · Filed Jul 14, 2021

Insider Transaction Report

Form 4
Period: 2021-07-13
Smith L. Mary
See Remarks
Transactions
  • Exercise/Conversion

    Common Stock

    2021-07-13$2.30/sh+10,000$23,000177,511 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-07-1310,00094,296 total
    Exercise: $2.30Exp: 2029-04-22Common Stock (10,000 underlying)
  • Sale

    Common Stock

    2021-07-13$80.88/sh10,000$808,777167,511 total
Footnotes (4)
  • [F1]The stock option exercises and sale transactions reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $80.115 to $83.54, inclusive.
  • [F3]Includes 27,304 restricted stock awards which are subject to forfeiture until they vest.
  • [F4]This option began to vest and become exercisable in 48 equal monthly installments beginning on April 22, 2019.

Documents

1 file
  • 4
    tm2122166d1_4.xmlPrimary

    OWNERSHIP DOCUMENT